What is Manifold Bio?
Manifold Bio is a biotechnology company dedicated to advancing the development of life-saving therapeutics. Its core mission revolves around harnessing the power of multiplexed measurement to engineer novel treatments. Operating within the dynamic biotech landscape, the company aims to address critical unmet medical needs through innovative scientific approaches. The recent major strategic investment suggests a pivotal moment for Manifold Bio as it scales its operations and R&D efforts.
How much funding has Manifold Bio raised?
Manifold Bio has raised a total of $45.4M across 2 funding rounds:
Angel/Seed
$5.4M
Series A
$40M
Angel/Seed (2020): $5.4M with participation from Fifty Years, Allston Venture Fund, GETTYLAB, and Playground Global
Series A (2022): $40M led by Triatomic Capital, Fifty Years, Playground Global, Tencent, FPV Ventures, Horizons Ventures, and Section 32
Key Investors in Manifold Bio
Fifty Years
Fifty Years is a venture capital firm focused on early-stage deep tech startups addressing global challenges. They provide support for founders leveraging technology in areas like climate change and disease.
Tencent
Tencent is a global technology conglomerate offering internet and mobile services, including online gaming and instant messaging. They are a significant player in the international tech market.
Playground Global
Playground Global invests in founders using frontier technologies to build transformational businesses, with a focus on AI, automation, and life sciences.
What's next for Manifold Bio?
With the infusion of $40M in its latest strategic investment, Manifold Bio is poised for accelerated development and expansion. This significant capital injection, contributing to a total funding of $45.4M, will likely fuel further research into its therapeutic platforms, enhance its engineering capabilities, and potentially support clinical trial progression. The company's focus on multiplexed measurement positions it at the forefront of precision medicine, suggesting a future centered on targeted and effective therapeutic solutions. Strategic partnerships and continued innovation will be key as Manifold Bio navigates the competitive biopharmaceutical industry.
See full Manifold Bio company page
